PANCREATIC ADENOCARCINOMA METASTATIC
Clinical trials for PANCREATIC ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to outsmart pancreatic cancer resistance
Disease control OngoingThis study tests whether adding two experimental drugs (elraglusib and losartan) to standard chemotherapy (FOLFIRINOX) can prevent metastatic pancreatic cancer from becoming resistant to treatment. About 70 adults with untreated, advanced pancreatic cancer will receive the combin…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New cocktail of drugs takes on tough pancreatic cancer
Disease control OngoingThis early-phase trial tests whether adding two immune-boosting drugs (botensilimab and balstilimab) to a strong chemotherapy mix plus two oral medications (chloroquine and celecoxib) can help people with metastatic pancreatic cancer that hasn't been treated yet. The study includ…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated May 26, 2026 12:07 UTC